Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how-Reference-Cited by-同舟云学术

Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how

Published:2021-11-22 Issue: Volume: Page:
ISSN:1464-7931
Container-title:Biological Reviews
language:en
Short-container-title:Biol Rev

Author:

Wang Yan¹^ORCID,Guo Fuzheng¹^ORCID

Affiliation:

1. Department of Neurology, Shriners Hospitals for Children/School of Medicine, Institute for Pediatric Regenerative Medicine (IPRM) University of California, Davis 2425 Stockton Blvd Sacramento CA 95817 U.S.A.

Funder

National Institute of Neurological Disorders and Stroke

Shriners Hospitals for Children

Publisher

Wiley

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/brv.12815

Reference174 articles.

1. Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase

2. PAK3 mutation in nonsyndromic X-linked mental retardation

3. Pak1 Kinase Links ErbB2 to β-Catenin in Transformation of Breast Epithelial Cells

4. Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1)

5. Pak1 Phosphorylation on T212 Affects Microtubules in Cells Undergoing Mitosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4;MedComm;2024-09

2. Antagonistic actions of PAK1 and NF2/Merlin drive myelin membrane expansion in oligodendrocytes;Glia;2024-05-25

3. Targeting endothelial PDGFR‐β facilitates angiogenesis‐associated bone formation through the PAK1/NICD axis;Journal of Cellular Physiology;2024-05-09

4. Control of OPC proliferation and repopulation by the intellectual disability gene PAK1 under homeostatic and demyelinating conditions;2024-04-29

5. Ade novovariant inPAK2detected in an individual with Knobloch type 2 syndrome;2024-04-22